期刊文献+

阿托伐他汀对2型糖尿病老年患者颈部动脉斑块的影响 被引量:3

Effect of atorvastatin on carotid atherosclerosis plaque in patients with type 2 diabetes mellitus
在线阅读 下载PDF
导出
摘要 目的探讨阿托伐他汀对2型糖尿病老年患者颈部动脉斑块的影响。方法 2型糖尿病老年患者50例为研究对象,将所有患者按照随机对照的原则分为治疗组(25例)和对照组(25例),对照组患者入院后常规控制血糖在正常范围。治疗组在此基础上还服用阿托伐他汀片。观察两组治疗前后TC、TG、LDL-C、HDL-C、血管斑块大小及颈内动脉内膜中层厚度变化情况。结果与对照组比较,治疗组TC、TG、LDL-C减低更明显,HDL-C升高更明显,其差异均有统计学意义(P<0.05)。治疗组斑块大小和颈内动脉内膜中层厚度较对照组减低更明显,其差异均有统计学意义(P<0.05)。结论阿托伐他汀能明显缩小2型糖尿病老年患者颈部动脉斑块大小,值得临床应用。 Objective To investigate the effect of atorvastatin on plaque formation of carotid arteries in elderly patients with type 2diabetes. Methods Fifty elderly patients with type 2 diabetes from 2010 February to 2012 October in our hospital were selected as the object of study. All patients were randomly divided into treatment group(25 cases) and control group(25 cases). Blood sugar in control group was controlled in normal range. The treatment group,on this basis,used oral atorvastatin. The changes of TC,TG,LDL- C,HDL- C,vascular plaque size and internal carotid artery intima- media thickness in the two groups were observed before and after treatment. Results Compared with the control group,TC,TG and LDL- C in treatment group decreased significantly,and HDL- C in treatment group increased obviously,and the differences were statistically significant( P < 0. 05). Compared with control group,the patch size and CIMT in treatment group decreased more significantly,and the differences were statistically significant( P < 0. 05). Conclusion Atorvastatin can significantly reduce carotid artery plaque size in elderly patients with type 2 diabetes,which is worth clinical using.
作者 夏静芬
出处 《安徽医学》 2013年第10期1529-1531,共3页 Anhui Medical Journal
关键词 阿托伐他汀 糖尿病 动脉斑块 颈部 Atorvastatin Diabetes Arteriosclerosis of carotid arteries
  • 相关文献

参考文献8

二级参考文献42

  • 1詹晓蓉,肖彧君,母义明,李明,陆祖谦,陆菊明,潘长玉.花生四烯酸对饱和脂肪酸的血管内皮细胞毒性的保护作用[J].中华内分泌代谢杂志,2004,20(5):453-456. 被引量:9
  • 2李延兵,翁建平.保护β细胞功能以改善2型糖尿病的自然病程[J].国外医学(内分泌学分册),2005,25(3):181-183. 被引量:76
  • 3Rosuvastatin Registration Clinical Trial Group.Cardiovascular Institute and Fu Wai Hospital,Peking Union Medical College and Chinese Academy of Medical Science,Beijing 100037,China.瑞舒伐他汀治疗中国高胆固醇血症患者疗效和安全性的随机双盲多中心对照研究[J].中华心血管病杂志,2007,35(3):207-211. 被引量:117
  • 4李洪林,杨思进.他汀类药物调脂作用外的临床研究进展[J].中国药房,2007,18(17):1352-1354. 被引量:8
  • 5Komowski R,Hone MK,Tio FO,et al.In-stent restenosis contributions of inflammatory responscs and arterial injury to neointimal hyperpnlasia.J Am Coll Cardiol,1998,31(1):224-230.
  • 6Gu I,Tseng SC,Rollins BJ.Monocyte chemcoattractant protein-1.Chem Immunol,1999,72:7-29.
  • 7Cipollone F,Marini M,Fazia M,et al.Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty.Arterioscler Thromb Vasc Biol,2001,21(3):327-334.
  • 8de Winter RJ,Fischer JC,de Jongh T,et al.Different time frames for the occurrence of elevated levels of cardiac troponin T and C -reactive protein in patients with acute myocardial infarction.Clin Chem Lad Med,2000,38(11):1151-1153.
  • 9M(o)ckel M,Heller G Jr,Müller C,et al.C-reactive protein as an independent marker of prognosis in acute coronary syndrome:comparison with troponin T.Z Kardiol,2000,89(8):658-666.
  • 10Tousoulis D,Antoniades C,Katsi V,et al.The impact of early administration of low-dose atorvastatin treatment on inflammatory process,in patients with unstable angina and low cholesterol level.Int J Cardiol,2006,109(1):48-52.

共引文献148

同被引文献11

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部